STEPHANI ELLIOTT: Open Payments
NPI 1225640998 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,313 in 103 payments from 22 companies in 2025. Trend: 2023 $2,194 · 2024 $2,268 · 2025 $2,313
Food & beverage: $2,313
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $653 |
| Ardelyx, Inc. | 11 | $177 |
| QOL Medical, LLC | 7 | $176 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $149 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $139 |
| Phathom Pharmaceuticals, Inc. | 6 | $138 |
| Novo Nordisk Inc | 2 | $137 |
| Madrigal Pharmaceuticals | 5 | $118 |
| GENZYME CORPORATION | 3 | $87 |
| Regeneron Healthcare Solutions, Inc. | 3 | $64 |
Products named: RINVOQ, IBSRELA, Sucraid, DUPIXENT, ENTYVIO, VOQUEZNA, Wegovy, XIFAXAN.
Industry payments across TX — which companies pay providers there.
